Skip navigation

Panel Discussion • How to Interact with Advocacy Groups to Facilitate Access

Patient advocacy groups can serve as a great conduit between manufacturers and patients or their physicians seeking treatment options when traditional access channels for medicines are not available.  During this panel discussion, learn how advocacy groups can help facilitate the success of a Managed Access Program.

•    Establish ways advocacy groups can help educate patients and physicians about access options

•    Better understand the needs of the patient

•    Incorporate collective feedback from the groups serving as a representative voice of the patient

John Lagus
Vice President, New Product and Market Development
Dean Suhr
President, MLD Foundation; Chairman of the Patient Advocacy Advisory Board
RARE Project
Kim Ryan
Director of Patient Information Services
Fight Colorectal Cancer Foundation
Julie Fleshman JD, MBA
President & CEO
Pancreatic Cancer Action Network
Jill Panetta Ph.D.
Chief Scientific Officer